COVID19 Vaccines and Patent Protection
In this interview with Deutsche Welle, recorded 5/6/2021, I discuss how intellectual property rights are the engine of innovation that led to #COVID19 vaccines
Related Articles
Military and Veteran Benefits, News and Veteran Jobs
Military.com helps millions of military-connected Americans access military and veteran benefits and news, find jobs and enjoy military discounts.
One in Five Milk Samples Nationwide Shows Genetic Traces of Bird Flu
There is no evidence that the milk is unsafe to drink, scientists say. But the survey result strongly hints that the outbreak may be widespread.
Babies of dengue-infected pregnant women shown to be at high risk for poor health in first years of life
The newborns had a 67% and 133% greater risk of being classified as very and extremely low birth weight, respectively.
Impaired sense of smell still common 1 year after COVID-19
Participants with a history of COVID-19 were more likely to experience some degree of smell loss compared with those without a history.
GSK accuses Pfizer and BioNTech of mRNA patent infringement
GSK says it is owed a portion of Pfizer and BioNTech’s Covid-19 vaccine sales in the latest patent suit filed against the Comirnaty partners. In…
Fauci agrees to testify in Congress on covid origins, pandemic policies
It marks the first time infectious-disease doctor Anthony S. Fauci will publicly face Congress since leaving government.
More than a quarter of people with Covid infection develop Long Covid, new research reveals
A new study carried out by researchers at the University of York suggests 28% of people who catch COVID-19 will go on to suffer from…
F.D.A. Approves Antibiotic for Increasingly Hard-to-Treat Urinary Tract Infections
Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and older.
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Taking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19 symptom onset—not earlier or later—may result in…
Cidara buys back flu rights, sells antifungal and inks $240M PIPE
Cidara Therapeutics announced several sweeping moves on Wednesday afternoon to bring an influenza drug back in-house and raise money from investors to back the program.…